Connect Biopharma is trading 5.72% up now at $2.43 after closing at $2.30 on August 24, 2026; no new company-specific announcement, earnings release, regulatory update, or analyst action explaining the after-hours move was identified.
- The latest material update was the August 12 quarterly report, highlighting completed Phase 2 enrollment and September topline results.
- That news is stale and does not clearly explain the August 24 move.